Literature DB >> 23696515

Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials.

Mazen Noureddin1, Jessica Lam, Michael R Peterson, Michael Middleton, Gavin Hamilton, Thuy-Anh Le, Ricki Bettencourt, Chris Changchien, David A Brenner, Claude Sirlin, Rohit Loomba.   

Abstract

UNLABELLED: The magnetic resonance imaging-estimated proton density fat fraction (MRI-PDFF) is a novel imaging-based biomarker that allows fat mapping of the entire liver, whereas the magnetic resonance spectroscopy-measured proton density fat fraction (MRS-PDFF) provides a biochemical measure of liver fat in small regions of interest. Cross-sectional studies have shown that MRI-PDFF correlates with MRS-PDFF. The aim of this study was to show the utility of MRI-PDFF in assessing quantitative changes in liver fat through a three-way comparison of MRI-PDFF and MRS-PDFF with the liver histology-determined steatosis grade at two time points in patients with nonalcoholic fatty liver disease (NAFLD). Fifty patients with biopsy-proven NAFLD who participated in a randomized trial underwent a paired evaluation with liver biopsy, MRI-PDFF, and MRS-PDFF at the baseline and 24 weeks. The mean age and body mass index were 47.8 ± 11.7 years and 30.7 ± 6.5 kg/m(2), respectively. MRI-PDFF showed a robust correlation with MRS-PDFF both at week 0 and at week 24 (r = 0.98, P < 0.0001 for both). Cross-sectionally, MRI-PDFF and MRS-PDFF increased with increases in the histology-determined steatosis grade both at week 0 and at week 24 (P < 0.05 for all). Longitudinally, patients who had a decrease (≥ 1%) or increase (≥ 1%) in MRI-PDFF (confirmed by MRS-PDFF) showed a parallel decrease or increase in their body weight and serum alanine aminotransferase and aspartate aminotransferase levels at week 24 (P < 0.05). This small increase or decrease in liver fat could not be quantified with histology.
CONCLUSION: In this longitudinal study, MRI-PDFF correlated well with MRS-PDFF and was more sensitive than the histology-determined steatosis grade in quantifying increases or decreases in the liver fat content. Therefore, it could be used to quantify changes in liver fat in future clinical trials.
© 2013 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23696515      PMCID: PMC4819962          DOI: 10.1002/hep.26455

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  41 in total

1.  Burden of liver disease in the United States: summary of a workshop.

Authors:  W Ray Kim; Robert S Brown; Norah A Terrault; Hashem El-Serag
Journal:  Hepatology       Date:  2002-07       Impact factor: 17.425

2.  Relaxation effects in the quantification of fat using gradient echo imaging.

Authors:  Mark Bydder; Takeshi Yokoo; Gavin Hamilton; Michael S Middleton; Alyssa D Chavez; Jeffrey B Schwimmer; Joel E Lavine; Claude B Sirlin
Journal:  Magn Reson Imaging       Date:  2008-02-21       Impact factor: 2.546

3.  Fat quantification with IDEAL gradient echo imaging: correction of bias from T(1) and noise.

Authors:  Chia-Ying Liu; Charles A McKenzie; Huanzhou Yu; Jean H Brittain; Scott B Reeder
Journal:  Magn Reson Med       Date:  2007-08       Impact factor: 4.668

4.  Non-invasive assessment of hepatic steatosis: prospective comparison of the accuracy of imaging examinations.

Authors:  Seung Soo Lee; Seong Ho Park; Hye Jin Kim; So Yeon Kim; Min-Yeong Kim; Dae Yoon Kim; Dong Jin Suh; Kang Mo Kim; Mi Hyun Bae; Joo Yeon Lee; Sung-Gyu Lee; Eun Sil Yu
Journal:  J Hepatol       Date:  2010-02-02       Impact factor: 25.083

5.  Where are we in the search for noninvasive nonalcoholic steatohepatitis biomarkers?

Authors:  José M Mato; Shelly C Lu
Journal:  Hepatology       Date:  2011-10       Impact factor: 17.425

6.  Noninvasive quantification of hepatic steatosis in rats using 3.0 T 1H-magnetic resonance spectroscopy.

Authors:  H A Marsman; J R van Werven; A J Nederveen; F J Ten Kate; M Heger; J Stoker; T M van Gulik
Journal:  J Magn Reson Imaging       Date:  2010-07       Impact factor: 4.813

7.  Reproducibility of MRI-determined proton density fat fraction across two different MR scanner platforms.

Authors:  Geraldine H Kang; Irene Cruite; Masoud Shiehmorteza; Tanya Wolfson; Anthony C Gamst; Gavin Hamilton; Mark Bydder; Michael S Middleton; Claude B Sirlin
Journal:  J Magn Reson Imaging       Date:  2011-07-18       Impact factor: 4.813

8.  Association between diabetes, family history of diabetes, and risk of nonalcoholic steatohepatitis and fibrosis.

Authors:  Rohit Loomba; Maria Abraham; Aynur Unalp; Laura Wilson; Joel Lavine; Ed Doo; Nathan M Bass
Journal:  Hepatology       Date:  2012-07-26       Impact factor: 17.425

Review 9.  Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications.

Authors:  Kenneth Cusi
Journal:  Gastroenterology       Date:  2012-02-08       Impact factor: 22.682

10.  Unenhanced CT for assessment of macrovesicular hepatic steatosis in living liver donors: comparison of visual grading with liver attenuation index.

Authors:  Sang Won Lee; Seong Ho Park; Kyoung Won Kim; Eugene K Choi; Yong Moon Shin; Pyo Nyun Kim; Kyoung Ho Lee; Eun Sil Yu; Shin Hwang; Sung-Gyu Lee
Journal:  Radiology       Date:  2007-08       Impact factor: 11.105

View more
  165 in total

1.  Heritability of Hepatic Fibrosis and Steatosis Based on a Prospective Twin Study.

Authors:  Rohit Loomba; Nicholas Schork; Chi-Hua Chen; Ricki Bettencourt; Ana Bhatt; Brandon Ang; Phirum Nguyen; Carolyn Hernandez; Lisa Richards; Joanie Salotti; Steven Lin; Ekihiro Seki; Karen E Nelson; Claude B Sirlin; David Brenner
Journal:  Gastroenterology       Date:  2015-08-20       Impact factor: 22.682

2.  Hepatic fat quantification using the proton density fat fraction (PDFF): utility of free-drawn-PDFF with a large coverage area.

Authors:  Kun Young Kim; Ji Soo Song; Stephan Kannengiesser; Young Min Han
Journal:  Radiol Med       Date:  2015-05-08       Impact factor: 3.469

3.  Comparative diagnostic accuracy of magnetic resonance elastography vs. eight clinical prediction rules for non-invasive diagnosis of advanced fibrosis in biopsy-proven non-alcoholic fatty liver disease: a prospective study.

Authors:  J Cui; B Ang; W Haufe; C Hernandez; E C Verna; C B Sirlin; R Loomba
Journal:  Aliment Pharmacol Ther       Date:  2015-04-15       Impact factor: 8.171

Review 4.  Nonalcoholic fatty liver disease: update on pathogenesis, diagnosis, treatment and the role of S-adenosylmethionine.

Authors:  Mazen Noureddin; José M Mato; Shelly C Lu
Journal:  Exp Biol Med (Maywood)       Date:  2015-04-13

5.  Usefulness of Controlled Attenuation Parameter in Detecting and Monitoring Hepatic Steatosis with MRI-PDFF as Reference.

Authors:  Jing-Houng Wang; Hsin-You Ou; Yi-Hao Yen; Chien-Hung Chen; Sheng-Nan Lu
Journal:  Dig Dis Sci       Date:  2019-10-15       Impact factor: 3.199

6.  Standardized Approach for ROI-Based Measurements of Proton Density Fat Fraction and R2* in the Liver.

Authors:  Camilo A Campo; Diego Hernando; Tilman Schubert; Candice A Bookwalter; Andrew J Van Pay; Scott B Reeder
Journal:  AJR Am J Roentgenol       Date:  2017-07-13       Impact factor: 3.959

7.  Comparison between modified Dixon MRI techniques, MR spectroscopic relaxometry, and different histologic quantification methods in the assessment of hepatic steatosis.

Authors:  Guido M Kukuk; Kanishka Hittatiya; Alois M Sprinkart; Holger Eggers; Jürgen Gieseke; Wolfgang Block; Philipp Moeller; Winfried A Willinek; Ulrich Spengler; Jonel Trebicka; Hans-Peter Fischer; Hans H Schild; Frank Träber
Journal:  Eur Radiol       Date:  2015-04-23       Impact factor: 5.315

8.  Serum microRNAs explain discordance of non-alcoholic fatty liver disease in monozygotic and dizygotic twins: a prospective study.

Authors:  Amir Zarrinpar; Shakti Gupta; Mano R Maurya; Shankar Subramaniam; Rohit Loomba
Journal:  Gut       Date:  2015-05-22       Impact factor: 23.059

9.  How bariatric surgery affects liver volume and fat density in NAFLD patients.

Authors:  Ran B Luo; Toshiaki Suzuki; Jonathan C Hooker; Yesenia Covarrubias; Alexandra Schlein; Shanglei Liu; Jeffrey B Schwimmer; Scott B Reeder; Luke M Funk; Jacob A Greenberg; Guilherme M Campos; Bryan J Sandler; Santiago Horgan; Claude B Sirlin; Garth R Jacobsen
Journal:  Surg Endosc       Date:  2017-12-07       Impact factor: 4.584

Review 10.  Liver fat imaging-a clinical overview of ultrasound, CT, and MR imaging.

Authors:  Yingzhen N Zhang; Kathryn J Fowler; Gavin Hamilton; Jennifer Y Cui; Ethan Z Sy; Michelle Balanay; Jonathan C Hooker; Nikolaus Szeverenyi; Claude B Sirlin
Journal:  Br J Radiol       Date:  2018-06-06       Impact factor: 3.039

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.